Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to non-sensitized patients

S Heidt*, G W Haasnoot, M D Witvliet, M J H van der Linden-van Oevelen, E G Kamburova, B W Wisse, I Joosten, W A Allebes, A van der Meer, L B Hilbrands, M C Baas, E Spierings, C E Hack, F E van Reekum, A D van Zuilen, M C Verhaar, M L Bots, A C A D Drop, L Plaisier, M A J SeelenJ S F Sanders, B G Hepkema, A J Lambeck, L B Bungener, C Roozendaal, M G J Tilanus, C E Voorter, L Wieten, E M van Duijnhoven, M Gelens, M H L Christiaans, F J van Ittersum, A Nurmohamed, N M Lardy, W Swelsen, K A van der Pant, N C van der Weerd, I J M Ten Berge, F J Bemelman, A Hoitsma, P J M van der Boog, J W de Fijter, M G H Betjes, H G Otten, D L Roelen, F H J Claas

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)
212 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to non-sensitized patients'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology